WallStreetZenWallStreetZen

NYSE: CCJ
Cameco Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CCJ past earnings growth

How has CCJ's earnings growth performed historically?
Company
287.58%
Industry
211.15%
Market
72.61%
CCJ's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CCJ's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CCJ's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CCJ past revenue growth

How has CCJ's revenue growth performed historically?
Company
42.7%
Industry
1,357.34%
Market
17.55%
CCJ's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CCJ's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CCJ's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CCJ earnings and revenue history

Current Revenue
$1.9B
Current Earnings
$271.3M
Current Profit Margin
13.9%
CCJ's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

CCJ Return on Equity

Current Company
6%
Current Industry
-8.1%
Current Market
188%
CCJ's Return on Equity (6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CCJ announces earnings.

CCJ Return on Assets

Current Company
3.9%
Current Industry
5.4%
CCJ is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CCJ Return on Capital Employed

Current Company
6.9%
Current Industry
7.4%
CCJ has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CCJ vs Uranium Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CCJ$1.93B$614.46M$269.29M+4.66%+14.94%
NXE$0.00$56.48M$51.59MN/AN/A
UEC$59.39M-$2.46M-$4.87M+112.19%N/A
DNN$1.37M$72.95M$66.94M-34.44%+127.76%
UUUU$37.93M$102.89M$99.86M+3.64%+693.73%
View Top Uranium Stocks

CCJ earnings dates

Next earnings date
May 9, 2024

Cameco Earnings & Revenue FAQ

What were CCJ's earnings last quarter?

On Invalid Date, Cameco (NYSE: CCJ) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Cameco earnings for the quarter were N/A. In the same quarter last year, Cameco's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Cameco stock.

What was CCJ's earnings growth in the past year?

As of Q2 2024, Cameco's earnings has grown 287.58% year over year. This is 76.42 percentage points higher than the US Uranium industry earnings growth rate of 211.15%. Cameco's earnings in the past year totalled $269.29 million.

What is CCJ's earnings date?

Cameco's earnings date is Invalid Date. Add CCJ to your watchlist to be reminded of CCJ's next earnings announcement.

What was CCJ's revenue last quarter?

On Invalid Date, Cameco (NYSE: CCJ) reported Q4 2023 revenue of N/A up N/A year over year. In the same quarter last year, Cameco's revenue was N/A.

What was CCJ's revenue growth in the past year?

As of Q2 2024, Cameco's revenue has grown 42.7% year over year. This is 1,314.64 percentage points lower than the US Uranium industry revenue growth rate of 1,357.34%. Cameco's revenue in the past year totalled $1.93 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.